Product Images Advair Hfa

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Advair Hfa NDC 50090-4504 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Fluticasone chemical structure - advairhfa spl graphic 01

Fluticasone chemical structure - advairhfa spl graphic 01

Salmeterol chemical structure - advairhfa spl graphic 02

Salmeterol chemical structure - advairhfa spl graphic 02

Figure 1. Mean Percent Change from Baseline in FEV1 in Subjects Previously Treated with Either Beta2 agonists (Albuterol or Salmeterol) or Inhaled Corticosteroids (Trial 1) - advairhfa spl graphic 03

Figure 1. Mean Percent Change from Baseline in FEV1 in Subjects Previously Treated with Either Beta2 agonists (Albuterol or Salmeterol) or Inhaled Corticosteroids (Trial 1) - advairhfa spl graphic 03

Figure 2. Mean Percent Change from Baseline in Morning Peak Expiratory Flow in Subjects Previously Treated with Inhaled Corticosteroids (Trial 4) - advairhfa spl graphic 04

Figure 2. Mean Percent Change from Baseline in Morning Peak Expiratory Flow in Subjects Previously Treated with Inhaled Corticosteroids (Trial 4) - advairhfa spl graphic 04

Not Available.*

Figure 3. Percent Change in Serial 12-Hour FEV1 in Subjects Previously Using Either Beta2-agonists (Albuterol or Salmeterol) or Inhaled Corticosteroids (Trial 1) - advairhfa spl graphic 05

Figure 3. Percent Change in Serial 12-Hour FEV1 in Subjects Previously Using Either Beta2-agonists (Albuterol or Salmeterol) or Inhaled Corticosteroids (Trial 1) - advairhfa spl graphic 05

This text appears to be a comparison of the change in FEV (Forced Expiratory Volume) between two different inhalers. One is ADVAIR HFA 45 mog/21 meg, taken twice daily by 92 participants, while the other is a combination of Fluticasone propionate inhalation aerosol 44 meg and Salmeterol inhalation aerosol 21 meg, taken twice daily by 89 participants. The change in FEV is being evaluated over a period of time, starting from Day 1 baseline.*

Figure 4. Percent Change in Serial 12-Hour FEV1 in Subjects Previously Using Either Beta2-agonists (Albuterol or Salmeterol) or Inhaled Corticosteroids (Trial 1) - advairhfa spl graphic 06

Figure 4. Percent Change in Serial 12-Hour FEV1 in Subjects Previously Using Either Beta2-agonists (Albuterol or Salmeterol) or Inhaled Corticosteroids (Trial 1) - advairhfa spl graphic 06

Figure A - advairhfa spl graphic 07

Figure A - advairhfa spl graphic 07

Figure B - advairhfa spl graphic 08

Figure B - advairhfa spl graphic 08

Figure C - advairhfa spl graphic 09

Figure C - advairhfa spl graphic 09

Figure D - advairhfa spl graphic 10

Figure D - advairhfa spl graphic 10

Figure E - advairhfa spl graphic 11

Figure E - advairhfa spl graphic 11

Figure F - advairhfa spl graphic 12

Figure F - advairhfa spl graphic 12

Figure G - advairhfa spl graphic 13

Figure G - advairhfa spl graphic 13

Figure H - advairhfa spl graphic 14

Figure H - advairhfa spl graphic 14

Figure I - advairhfa spl graphic 15

Figure I - advairhfa spl graphic 15

Figure J - advairhfa spl graphic 16

Figure J - advairhfa spl graphic 16

Label Image - lbl500904504

Label Image - lbl500904504

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.